Genmab A/SGMABNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+21.4%
5Y CAGR+26.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+21.4%/yr
vs +40.4%/yr prior
5Y CAGR
+26.0%/yr
Recent deceleration
Acceleration
-19.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$9.94B+2.0%
2024$9.75B+27.8%
2023$7.63B+37.2%
2022$5.56B+33.0%
2021$4.18B+33.3%
2020$3.14B+31.5%
2019$2.39B+66.7%
2018$1.43B+63.7%
2017$874.28M+32.3%
2016$660.88M-